Jeffrey D Bradley Selected Research

Jeffrey D Bradley Research Topics

Disease

74	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2002
41	Neoplasms (Cancer) 02/2024 - 01/2002
32	Lung Neoplasms (Lung Cancer) 12/2023 - 06/2003
6	Disease Progression 08/2023 - 03/2011
6	Pneumonia (Pneumonitis) 08/2023 - 03/2011
6	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2004
6	Esophagitis 01/2017 - 02/2003
6	Radiation Pneumonitis 05/2015 - 11/2007
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 08/2004
3	Cardiotoxicity 12/2023 - 01/2017
3	Adenocarcinoma 12/2017 - 08/2006
3	Weight Loss (Weight Reduction) 04/2012 - 02/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 04/2015
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 12/2017
2	Brain Neoplasms (Brain Tumor) 08/2014 - 06/2012
2	Lung Injury 07/2011 - 03/2011
2	Breast Neoplasms (Breast Cancer) 11/2005 - 12/2004
1	Death (Near-Death Experience) 03/2024
1	Lymphopenia (Lymphocytopenia) 01/2024
1	Acute Coronary Syndrome 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Heart Failure 11/2023
1	Coronary Disease (Coronary Heart Disease) 11/2023
1	Prostatic Neoplasms (Prostate Cancer) 09/2023
1	Pain (Aches) 01/2023
1	Carcinoma (Carcinomatosis) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Compression Fractures (Compression Fracture) 10/2020
1	Spinal Cord Compression 10/2020
1	Necrosis 01/2018
1	Astrocytoma (Pilocytic Astrocytoma) 01/2018
1	Glioma (Gliomas) 01/2018
1	Oligodendroglioma 01/2018
1	Small Cell Carcinoma 01/2017
1	Hydrocephalus (Hydrocephaly) 08/2014
1	Seizures (Absence Seizure) 08/2014
1	Neurologic Manifestations (Neurological Manifestations) 08/2014

Drug/Important Bio-Agent (IBA)

8	Protons (Proton)IBA 02/2024 - 05/2016
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2011
5	durvalumabIBA 01/2024 - 01/2021
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2017
5	PlatinumIBA 09/2021 - 03/2015
5	Carboplatin (JM8)FDA LinkGeneric 02/2015 - 05/2005
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2015 - 05/2005
3	Cetuximab (Erbitux)FDA Link 10/2023 - 02/2015
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016 - 11/2006
2	SolutionsIBA 09/2023 - 12/2020
2	pembrolizumabIBA 08/2023 - 01/2020
2	NivolumabIBA 09/2021 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2018 - 09/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 07/2012
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 07/2012
1	omega-Chloroacetophenone (Mace)IBA 11/2023
1	MicroRNAs (MicroRNA)IBA 10/2023
1	MetalsIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	IpilimumabIBA 09/2021
1	Metformin (Glucophage)FDA LinkGeneric 09/2021
1	NAD (NADH)IBA 01/2021
1	talazoparibIBA 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	telisotuzumab vedotinIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	tremelimumabIBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	AZD4547IBA 10/2019
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 10/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2019
1	Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA 10/2019
1	Carbon DioxideIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	Panitumumab (Vectibix)FDA Link 01/2017
1	Pemetrexed (MTA)FDA Link 03/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	GadoliniumIBA 08/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2014

Therapy/Procedure

82	Radiotherapy 02/2024 - 01/2002
21	Therapeutics 11/2023 - 01/2002
19	Drug Therapy (Chemotherapy) 10/2023 - 01/2002
9	Chemoradiotherapy 11/2020 - 08/2006
7	Proton Therapy 03/2024 - 05/2016
5	Immunotherapy 08/2023 - 01/2017
4	Re-Irradiation 08/2023 - 01/2020
4	Conformal Radiotherapy 02/2015 - 02/2003
3	Combined Modality Therapy 01/2019 - 08/2006
2	Esophagectomy 01/2019 - 12/2017
2	Aftercare (After-Treatment) 09/2015 - 01/2013
2	Pneumonectomy (Lung Volume Reduction) 02/2013 - 07/2010
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024
1	Treatment Delay 01/2023
1	Palliative Care (Palliative Therapy) 12/2017
1	Cranial Irradiation 10/2017
1	Induction Chemotherapy 09/2017
1	Consolidation Chemotherapy 01/2017
1	Adjuvant Chemotherapy 03/2015